XCELLERATE CLINICAL TRIAL OPTIMIZATION
Dead / Cancelled — Cancelled — Section 8 (as of 02 Dec 2022)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 85421531
- Registration number
- 4145934
- Mark type
- Stylized text
- Filed
- 13 Sept 2011
- Published for opposition
- 06 Mar 2012
- Registered
- 22 May 2012
- Attorney of record
- William M. Bryner
Goods and services
- Class 042 — Scientific and technological services: conducting clinical trials of pharmaceuticals and medical devices; scientific research services, namely, tracking, analyzing, forecasting, and reporting data in the field of clinical trials of pharmaceuticals and medical devices
Owner
- LABCORP DRUG DEVELOPMENT INC., PRINCETON, NJ, US
- Covance Inc., Princeton, NJ, US
- Covance Inc., Princeton, NJ, US
- Covance Inc., Princeton, NJ, US
Prosecution history
- 02 Dec 2022 — CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
- 07 Sept 2022 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 22 May 2021 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 06 Jun 2018 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 06 Jun 2018 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 06 Jun 2018 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 22 May 2018 — TEAS SECTION 8 & 15 RECEIVED
- 22 May 2017 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 22 May 2012 — REGISTERED-PRINCIPAL REGISTER
- 06 Mar 2012 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 06 Mar 2012 — PUBLISHED FOR OPPOSITION
- 15 Feb 2012 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 30 Jan 2012 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 26 Jan 2012 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 26 Jan 2012 — TEAS/EMAIL CORRESPONDENCE ENTERED